BACKGROUND: Vascular calcification is highly prevalent in persons with chronic kidney disease (CKD) and predicts cardiovascular disease (CVD) events. Matrix Gla protein (MGP) is a potent inhibitor of vascular calcification, and lower levels of its precursor-uncarboxylated MGP (ucMGP)--are associated with vascular calcification and atherosclerosis. Whether mild to moderate decrements in kidney function are associated with lower serum ucMGP is unknown. METHODS: In a cross-sectional study among 842 outpatients with stable CVD, estimated glomerular filtration rate (eGFR), serum cystatin-C and urine albumin-to-creatinine ratio (ACR) were measured and serum ucMGP levels were determined by ELISA. Multivariate linear regression evaluated the association of each kidney function measure with serum ucMGP levels. RESULTS: The mean eGFR was 76 +/- 23 mL/min/1.73 m(2), and 186 subjects (22%) had moderate CKD (eGFR <60 mL/min/1.73 m(2)). The mean +/- SD ucMGP level was 3289 +/- 1177 nM. In unadjusted analysis, each 10 mL/ min/1.73 m(2) lower eGFR was associated with 101 nM lower ucMGP level. This association was only minimally attenuated in final multivariate models wherein each 10 mL/ min/1.73 m(2) lower eGFR was associated with 79 nM lower ucMGP (95% confidence interval [CI]; 44 to 115; P < 0.001) after adjustment for age, sex, race, body mass index, blood pressure, smoking, hypertension, diabetes; and serum albumin, calcium, phosphorus, and fetuin-A levels. Similarly, in models adjusted for identical covariates, each 0.1 mg/L higher cystatin-C was associated with 39 nM lower ucMGP (95% CI 23 to 55; P < 0.001). In contrast, no significant association was observed between ACR and ucMGP in either unadjusted or adjusted analyses (adjusted P = 0.17). All associations were similar among subjects with or without diabetes (P-values for interaction > 0.50). CONCLUSIONS: Among outpatients with stable CVD, a reduced glomerular filtration rate is associated with a decreased serum ucMGP level. In contrast, ACR is not associated with ucMGP levels. Whether ucMGP is a useful marker of vascular calcification and CVD event risk in persons with CKD deserves future study.
BACKGROUND:Vascular calcification is highly prevalent in persons with chronic kidney disease (CKD) and predicts cardiovascular disease (CVD) events. Matrix Gla protein (MGP) is a potent inhibitor of vascular calcification, and lower levels of its precursor-uncarboxylated MGP (ucMGP)--are associated with vascular calcification and atherosclerosis. Whether mild to moderate decrements in kidney function are associated with lower serum ucMGP is unknown. METHODS: In a cross-sectional study among 842 outpatients with stable CVD, estimated glomerular filtration rate (eGFR), serum cystatin-C and urine albumin-to-creatinine ratio (ACR) were measured and serum ucMGP levels were determined by ELISA. Multivariate linear regression evaluated the association of each kidney function measure with serum ucMGP levels. RESULTS: The mean eGFR was 76 +/- 23 mL/min/1.73 m(2), and 186 subjects (22%) had moderate CKD (eGFR <60 mL/min/1.73 m(2)). The mean +/- SD ucMGP level was 3289 +/- 1177 nM. In unadjusted analysis, each 10 mL/ min/1.73 m(2) lower eGFR was associated with 101 nM lower ucMGP level. This association was only minimally attenuated in final multivariate models wherein each 10 mL/ min/1.73 m(2) lower eGFR was associated with 79 nM lower ucMGP (95% confidence interval [CI]; 44 to 115; P < 0.001) after adjustment for age, sex, race, body mass index, blood pressure, smoking, hypertension, diabetes; and serum albumin, calcium, phosphorus, and fetuin-A levels. Similarly, in models adjusted for identical covariates, each 0.1 mg/L higher cystatin-C was associated with 39 nM lower ucMGP (95% CI 23 to 55; P < 0.001). In contrast, no significant association was observed between ACR and ucMGP in either unadjusted or adjusted analyses (adjusted P = 0.17). All associations were similar among subjects with or without diabetes (P-values for interaction > 0.50). CONCLUSIONS: Among outpatients with stable CVD, a reduced glomerular filtration rate is associated with a decreased serum ucMGP level. In contrast, ACR is not associated with ucMGP levels. Whether ucMGP is a useful marker of vascular calcification and CVD event risk in persons with CKD deserves future study.
Authors: Christopher J O'Donnell; M Kyla Shea; Paul A Price; David R Gagnon; Peter W F Wilson; Martin G Larson; Douglas P Kiel; Udo Hoffmann; Maros Ferencik; Melvin E Clouse; Matthew K Williamson; L Adrienne Cupples; Bess Dawson-Hughes; Sarah L Booth Journal: Arterioscler Thromb Vasc Biol Date: 2006-09-14 Impact factor: 8.311
Authors: Leon J Schurgers; Kirsten J F Teunissen; Marjo H J Knapen; Martijn Kwaijtaal; Rob van Diest; Ad Appels; Chris P Reutelingsperger; Jack P M Cleutjens; Cees Vermeer Journal: Arterioscler Thromb Vasc Biol Date: 2005-06-16 Impact factor: 8.311
Authors: Cristianne Tomiyama; Andrea Higa; Maria A Dalboni; Miguel Cendoroglo; Sergio A Draibe; Lilian Cuppari; Aluizio B Carvalho; Emilio M Neto; Maria Eugenia F Canziani Journal: Nephrol Dial Transplant Date: 2006-05-30 Impact factor: 5.992
Authors: Suresh T Mathews; Sanjay Rakhade; Xiaohua Zhou; Graham C Parker; Donald V Coscina; George Grunberger Journal: Biochem Biophys Res Commun Date: 2006-09-25 Impact factor: 3.575
Authors: Wajeh Y Qunibi; Fadi Abouzahr; Mohammad R Mizani; Charles R Nolan; Rector Arya; Kelly J Hunt Journal: Kidney Int Date: 2005-07 Impact factor: 10.612
Authors: Andrew S Levey; Josef Coresh; Tom Greene; Lesley A Stevens; Yaping Lucy Zhang; Stephen Hendriksen; John W Kusek; Frederick Van Lente Journal: Ann Intern Med Date: 2006-08-15 Impact factor: 25.391
Authors: Michael G Shlipak; Ronit Katz; Mark J Sarnak; Linda F Fried; Anne B Newman; Catherine Stehman-Breen; Stephen L Seliger; Brian Kestenbaum; Bruce Psaty; Russell P Tracy; David S Siscovick Journal: Ann Intern Med Date: 2006-08-15 Impact factor: 25.391
Authors: Leon J Schurgers; Henri M H Spronk; Berry A M Soute; Paul M Schiffers; Jo G R DeMey; Cees Vermeer Journal: Blood Date: 2007-04-01 Impact factor: 22.113
Authors: Joachim H Ix; Glenn M Chertow; Michael G Shlipak; Vincent M Brandenburg; Markus Ketteler; Mary A Whooley Journal: Circulation Date: 2007-05-07 Impact factor: 29.690
Authors: Maria Fusaro; Maurizio Gallieni; Andrea Aghi; Maria Antonietta Rizzo; Giorgio Iervasi; Thomas L Nickolas; Fabrizio Fabris; Maria Cristina Mereu; Sandro Giannini; Stefania Sella; Andrea Giusti; Annalisa Pitino; Graziella D'Arrigo; Maurizio Rossini; Davide Gatti; Maura Ravera; Luca Di Lullo; Antonio Bellasi; Giuliano Brunori; Antonio Piccoli; Giovanni Tripepi; Mario Plebani Journal: J Nephrol Date: 2019-02-13 Impact factor: 3.902
Authors: Leon J Schurgers; Daniela V Barreto; Fellype C Barreto; Sophie Liabeuf; Cédric Renard; Elke J Magdeleyns; Cees Vermeer; Gabriel Choukroun; Ziad A Massy Journal: Clin J Am Soc Nephrol Date: 2010-02-04 Impact factor: 8.237
Authors: Benjamin D Parker; Leon J Schurgers; Cees Vermeer; Nelson B Schiller; Mary A Whooley; Joachim H Ix Journal: Atherosclerosis Date: 2009-11-22 Impact factor: 5.162